ELK3_HUMAN - dbPTM
ELK3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ELK3_HUMAN
UniProt AC P41970
Protein Name ETS domain-containing protein Elk-3
Gene Name ELK3
Organism Homo sapiens (Human).
Sequence Length 407
Subcellular Localization Nucleus.
Protein Description May be a negative regulator of transcription, but can activate transcription when coexpressed with Ras, Src or Mos. Forms a ternary complex with the serum response factor and the ETS and SRF motifs of the Fos serum response element..
Protein Sequence MESAITLWQFLLQLLLDQKHEHLICWTSNDGEFKLLKAEEVAKLWGLRKNKTNMNYDKLSRALRYYYDKNIIKKVIGQKFVYKFVSFPEILKMDPHAVEISRESLLLQDSDCKASPEGREAHKHGLAALRSTSRNEYIHSGLYSSFTINSLQNPPDAFKAIKTEKLEEPPEDSPPVEEVRTVIRFVTNKTDKHVTRPVVSLPSTSEAAAASAFLASSVSAKISSLMLPNAASISSASPFSSRSPSLSPNSPLPSEHRSLFLEAACHDSDSLEPLNLSSGSKTKSPSLPPKAKKPKGLEISAPPLVLSGTDIGSIALNSPALPSGSLTPAFFTAQTPNGLLLTPSPLLSSIHFWSSLSPVAPLSPARLQGPSTLFQFPTLLNGHMPVPIPSLDRAASPVLLSSNSQKS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MESAITLWQF
-----CHHHHHHHHH
24.5527732954
6Phosphorylation--MESAITLWQFLLQ
--CHHHHHHHHHHHH
22.9727732954
56PhosphorylationKNKTNMNYDKLSRAL
CCCCCCCHHHHHHHH
12.04-
58UbiquitinationKTNMNYDKLSRALRY
CCCCCHHHHHHHHHH
37.69-
83UbiquitinationIGQKFVYKFVSFPEI
HCCCHHEEECCHHHH
33.71-
92UbiquitinationVSFPEILKMDPHAVE
CCHHHHHCCCHHHHH
47.0921906983
92SumoylationVSFPEILKMDPHAVE
CCHHHHHCCCHHHHH
47.0928112733
104PhosphorylationAVEISRESLLLQDSD
HHHCCHHHHHCCCCC
24.1723403867
110PhosphorylationESLLLQDSDCKASPE
HHHHCCCCCCCCCCC
31.7630266825
113UbiquitinationLLQDSDCKASPEGRE
HCCCCCCCCCCCHHH
57.81-
115PhosphorylationQDSDCKASPEGREAH
CCCCCCCCCCHHHHH
14.6923401153
131PhosphorylationHGLAALRSTSRNEYI
HHHHHHHCCCCCCCC
31.4227251275
132PhosphorylationGLAALRSTSRNEYIH
HHHHHHCCCCCCCCC
25.8527251275
133PhosphorylationLAALRSTSRNEYIHS
HHHHHCCCCCCCCCC
34.0627251275
137PhosphorylationRSTSRNEYIHSGLYS
HCCCCCCCCCCCCCC
13.9029978859
140PhosphorylationSRNEYIHSGLYSSFT
CCCCCCCCCCCCCCE
22.4229978859
143PhosphorylationEYIHSGLYSSFTINS
CCCCCCCCCCCEECC
13.0429978859
144PhosphorylationYIHSGLYSSFTINSL
CCCCCCCCCCEECCC
24.8229978859
145PhosphorylationIHSGLYSSFTINSLQ
CCCCCCCCCEECCCC
16.9229978859
147PhosphorylationSGLYSSFTINSLQNP
CCCCCCCEECCCCCC
22.6129978859
150PhosphorylationYSSFTINSLQNPPDA
CCCCEECCCCCCCHH
27.7329978859
162SumoylationPDAFKAIKTEKLEEP
CHHHHHHHHHCCCCC
56.33-
162SumoylationPDAFKAIKTEKLEEP
CHHHHHHHHHCCCCC
56.33-
165SumoylationFKAIKTEKLEEPPED
HHHHHHHCCCCCCCC
67.4428112733
165UbiquitinationFKAIKTEKLEEPPED
HHHHHHHCCCCCCCC
67.44-
173PhosphorylationLEEPPEDSPPVEEVR
CCCCCCCCCCHHHHH
29.4623401153
189AcetylationVIRFVTNKTDKHVTR
HHHHHHCCCCCCCCC
49.0518584403
195O-linked_GlycosylationNKTDKHVTRPVVSLP
CCCCCCCCCCEECCC
29.0429351928
200O-linked_GlycosylationHVTRPVVSLPSTSEA
CCCCCEECCCCHHHH
34.4929351928
203O-linked_GlycosylationRPVVSLPSTSEAAAA
CCEECCCCHHHHHHH
50.2729351928
204O-linked_GlycosylationPVVSLPSTSEAAAAS
CEECCCCHHHHHHHH
28.7529351928
205O-linked_GlycosylationVVSLPSTSEAAAASA
EECCCCHHHHHHHHH
29.5829351928
211O-linked_GlycosylationTSEAAAASAFLASSV
HHHHHHHHHHHHHHH
18.1529351928
240PhosphorylationISSASPFSSRSPSLS
CCCCCCCCCCCCCCC
28.3824247654
243PhosphorylationASPFSSRSPSLSPNS
CCCCCCCCCCCCCCC
22.3130266825
245PhosphorylationPFSSRSPSLSPNSPL
CCCCCCCCCCCCCCC
42.6030266825
247PhosphorylationSSRSPSLSPNSPLPS
CCCCCCCCCCCCCCH
26.7730266825
250PhosphorylationSPSLSPNSPLPSEHR
CCCCCCCCCCCHHHH
31.0630266825
254PhosphorylationSPNSPLPSEHRSLFL
CCCCCCCHHHHHHHH
54.4327732954
258PhosphorylationPLPSEHRSLFLEAAC
CCCHHHHHHHHHHHC
25.9427732954
268PhosphorylationLEAACHDSDSLEPLN
HHHHCCCCCCCCCCC
12.8727732954
270PhosphorylationAACHDSDSLEPLNLS
HHCCCCCCCCCCCCC
38.2927732954
282PhosphorylationNLSSGSKTKSPSLPP
CCCCCCCCCCCCCCC
38.1523403867
284PhosphorylationSSGSKTKSPSLPPKA
CCCCCCCCCCCCCCC
25.5926657352
286PhosphorylationGSKTKSPSLPPKAKK
CCCCCCCCCCCCCCC
61.6723403867
357PhosphorylationIHFWSSLSPVAPLSP
HHHHHCCCCCCCCCH
21.1911042694
363PhosphorylationLSPVAPLSPARLQGP
CCCCCCCCHHHHCCC
18.5611042694
396PhosphorylationPSLDRAASPVLLSSN
CCCCCCCCCEEECCC
17.9829255136
401PhosphorylationAASPVLLSSNSQKS-
CCCCEEECCCCCCC-
24.2630266825
402PhosphorylationASPVLLSSNSQKS--
CCCEEECCCCCCC--
40.2323403867
404PhosphorylationPVLLSSNSQKS----
CEEECCCCCCC----
40.7223403867
407PhosphorylationLSSNSQKS-------
ECCCCCCC-------
37.5023403867

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
357SPhosphorylationKinaseJNK-SUBFAMILY-GPS
357SPhosphorylationKinaseJNK_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ELK3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ELK3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TFE2_HUMANTCF3physical
8918463
A4_HUMANAPPphysical
21832049

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ELK3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-396, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND MASSSPECTROMETRY.

TOP